Treatment · Supplement
Oxaloacetate
A metabolic supplement aimed squarely at long COVID fatigue. Early results looked striking, but the study design and funding warrant caution, and the evidence is not yet strong enough to call it effective.
Short version: oxaloacetate is a supplement that may reduce long COVID fatigue, but the early evidence is industry-funded with methodological caveats. Interesting signal, not yet proven.
A metabolic supplement for fatigue
Oxaloacetate is a molecule in the cell's energy cycle. The idea is that supplementing it supports mitochondrial energy production and reduces the fatigue that defines so much of long COVID.1
What the evidence says
An open-label study reported meaningful fatigue reduction in long COVID and ME/CFS, and a randomized follow-on has been run. But the early study was industry-funded with a historical (not concurrent) placebo, and editorial concerns have been raised, so the result needs cautious reading.1, 2
preliminary funding/method caveats
Honest framing
It is a supplement, not an approved drug, generally well tolerated but not cheap. The signal on fatigue is interesting; the evidence quality is not yet strong enough to call it effective.
What we don't know
Honest about the edges of the evidence. These are open questions, not settled answers.
- Whether benefit holds up in independent, concurrently controlled trials.
- The right dose.
- Who responds.
- Cost-effectiveness versus other approaches.
References
Every reference is free to read in full.